Prostate Cancer - Results from #26520

Pros and cons of focal therapy for localised prostate cancer - Abstract January 9, 2012

Complications, urinary continence, and oncologic outcomes of laparoscopic radical prostatectomy: Single-surgeon experience for the first 100 cases - Abstract January 9, 2012

Robot-assisted laparoscopic radical prostatectomy in the morbidly obese patient - Abstract January 9, 2012

Rectourinary fistula after radical prostatectomy: Review of the literature for incidence, etiology, and management - Abstract January 9, 2012

Contemporary radical prostatectomy - Abstract January 9, 2012

Role of signaling transduction pathways in development of castration-resistant prostate cancer - Abstract January 9, 2012

Oncologic outcomes of asian men with clinically localized prostate cancer after extraperitoneal laparoscopic radical prostatectomy: A single-institution experience - Abstract January 9, 2012

Development and external validation of a nomogram predicting the probability of significant Gleason sum upgrading among Japanese patients with localized prostate cancer - Abstract January 9, 2012

Mass prostate cancer screenings don’t reduce death January 9, 2012

Androgen deprivation causes epithelial-mesenchymal transition in the prostate: Implications for androgen-deprivation therapy - Abstract January 6, 2012

Patients' satisfaction with different modalities of prostate cancer therapy--a retrospective survey among 634 patients - Abstract January 6, 2012

Investigative clinical study on prostate cancer part VII: Prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population - Abstract January 6, 2012

Effect of zoledronic acid on bone mineral density in men with prostate cancer receiving gonadotropin-releasing hormone analog - Abstract January 6, 2012

Younger age is an independent predictor for poor survival in patients with signet ring prostate carcinoma - Abstract January 6, 2012

Beyond diagnosis: Evolving prostate biopsy in the era of focal therapy - Abstract January 6, 2012

Metabolic complications and increased cardiovascular risks as a result of androgen deprivation therapy in men with prostate cancer - Abstract January 6, 2012

Minimally invasive ablative therapies for definitive treatment of localized prostate cancer in the primary setting - Abstract January 6, 2012

An update on the changing indications for androgen deprivation therapy for prostate cancer - Abstract January 6, 2012

Temporal compartmental dosing effects for robotic prostate stereotactic body radiotherapy - Abstract January 5, 2012

Mathematical modeling of prostate cancer progression in response to androgen ablation therapy - Abstract January 5, 2012

Page 1327 of 1434